Multisystem Inflammatory Syndrome in Children (MIS-C) Overview

Save information for later
Sign Up

Learn About Multisystem Inflammatory Syndrome in Children (MIS-C)

What is the definition of Multisystem Inflammatory Syndrome in Children (MIS-C)?
Multisystem inflammatory syndrome in children (MIS-C) is a rare syndrome that appears to be linked to COVID-19 infection, in which different body organs become severely inflamed, such as the skin, eyes, brain, gastrointestinal system, heart, lungs, and kidneys.
What are the symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C)?
Symptoms of multisystem inflammatory syndrome in children can vary and require emergency treatment to prevent permanent organ damage. Symptoms may include fatigue, fever of 100.4° lasting 24 hours or longer, bloodshot eyes (conjunctivitis), rash, red, cracked lips, vomiting, diarrhea, severe abdominal pain, neck pain, difficulty breathing (dyspnea) or rapid breathing, cough, sore throat, chest pain or pressure, dizziness, confusion, loss of consciousness, bluish lips or face, low blood pressure, heart inflammation (myocarditis), rapid heartbeat, redness or swelling of lips, tongue (with red bumps), hands, or feet, and enlarged lymph nodes.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Multisystem Inflammatory Syndrome in Children (MIS-C)?
While treatment for children with multisystem inflammatory syndrome depends on the organs that are affected and the severity of the symptoms, children with this syndrome will usually need to be treated in the hospital by a multidisciplinary team with both supportive care (blood pressure medications, fluids, and oxygen to alleviate symptoms) and drugs to treat inflammation, such as antibiotics, steroid therapy, intravenous immunoglobulin (IVIG), and cytokine targeted therapies. Some children with this syndrome may need to be treated in the pediatric intensive care unit with ventilators, anticoagulants, and, in rare cases, extracorporeal membrane oxygenation.
Who are the top Multisystem Inflammatory Syndrome in Children (MIS-C) Local Doctors?
Jane Newburger
Elite in Multisystem Inflammatory Syndrome in Children (MIS-C)
Elite in Multisystem Inflammatory Syndrome in Children (MIS-C)

Department Of Cardiology

300 Longwood Ave, 
Boston, MA 
Languages Spoken:
English

Jane Newburger is a Pediatrics provider in Boston, Massachusetts. Dr. Newburger is rated as an Elite provider by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). Her top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Congenital Heart Disease (CHD), Heart Transplant, and Thrombectomy.

Elite in Multisystem Inflammatory Syndrome in Children (MIS-C)
Elite in Multisystem Inflammatory Syndrome in Children (MIS-C)

Department Of Cardiology

300 Longwood Ave, 
Boston, MA 
Languages Spoken:
English

Audrey Dionne is a Pediatrics provider in Boston, Massachusetts. Dr. Dionne is rated as an Elite provider by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). Her top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coronary Artery Aneurysm, Cardiac Ablation, and Heart Bypass Surgery.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Multisystem Inflammatory Syndrome in Children (MIS-C)
Pediatric Cardiology
Elite in Multisystem Inflammatory Syndrome in Children (MIS-C)
Pediatric Cardiology

CNMC Cardiology Dept

111 Michigan Avenue Northwest, Suite 200, Suite 200, 
Washington, DC 
Languages Spoken:
English, Arabic

Dr. Ashraf S. Harahsheh is a pediatric cardiologist affiliated with Sibley Memorial Hospital, George Washington University Hospital, Washington Adventist Hospital, Holy Cross Hospital, Calvert Memorial Hospital and Frederick Memorial Hospital. He practices out of Children’s National Medical Center in Washington, D.C. Dr. Harahsheh has expertise in arrhythmia, cardiology post-natal follow-up, heart murmurs, Kawasaki disease and syncope. He has clinical interest in atrial flutter and fibrillation in children with Wolff-Parkinson-White syndrome, the cardiac function in anthracycline-treated children and the use of B-type natriuretic peptide as a marker for worsening cardiac function. Dr. Harahsheh has been named a Who’s Who in Science and Engineering, one of America’s Top Pediatricians by Consumer’s Research Council of America and a Top 10 Cardiologist by Vitals. Dr. Harahsheh earned his medical degree from University of Jordan. He completed residencies in pediatrics at Children’s Hospital of Michigan, as well as a pediatric cardiology fellowship. Dr. Harahsheh is a member of the American Society of Echocardiography and the American College of Cardiology. Dr. Harahsheh has contributed to numerous publications. Dr. Harahsheh is rated as an Elite provider by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). His top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coronary Artery Aneurysm, Pediatric Myocarditis, and Heart Transplant.

What are the latest Multisystem Inflammatory Syndrome in Children (MIS-C) Clinical Trials?
A Cross Sectional Study of the Systems Immunology and Viral Diversity of SARS-CoV2 Infection, COVID-19 Disease and Multisystem Inflammatory Syndrome in Children

Objectives: To perform systems immunology and strain diversity among SARS-CoV2 and MIS-C infected children. Study design: Cross sectional study. Study population: Children attending outpatients units and admitted in wards in pediatric hospitals in Chennai. Main study parameters/endpoints: Immune responses in children with SARS-CoV2 infection and multisystem inflammatory syndrome in children (MIS-C) infection ...

Match to trials
Find the right clinical trials for you in under a minute
Get started